Skip to main content

Aortic Root Disease in Athletes: Aortic Root Dilation, Anomalous Coronary Artery, Bicuspid Aortic Valve, and Marfan’s Syndrome

Abstract

Two professional athletes in the US National Basketball Association required surgery for aortic root dilation in 2012. These cases have attracted attention in sports medicine to the importance of aortic root disease in athletes. In addition to aortic root dilation, other forms of aortic disease include anomalous coronary artery, bicuspid aortic valve, and Marfan’s syndrome. In this review, electronic database literature searches were performed using the terms “aortic root” and “athletes.” The literature search produced 122 manuscripts. Of these, 22 were on aortic root dilation, 21 on anomalous coronary arteries, 12 on bicuspid aortic valves, and 8 on Marfan’s syndrome. Aortic root dilation is a condition involving pathologic dilation of the aortic root, which can lead to life-threatening sequelae. Prevalence of the condition among athletes and higher risk athletes in particular sports needs to be better delineated. Normative parameters for aortic root diameter in the general population are proportionate to anthropomorphic variables, but this has not been validated for athletes at the extremes of anthropomorphic indices. Although echocardiography is the favored screening modality, computed tomography (CT) and cardiac magnetic resonance imaging (MRI) are also used for diagnosis and surgical planning. Medical management has utilized beta-blockers, with more recent use of angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), and statins. Indications for surgery are based on comorbidities, degree of dilation, and rate of progression. Management decisions for aortic root dilation in athletes are nuanced and will benefit from the development of evidence-based guidelines. Anomalous coronary artery is another form of aortic disease with relevance in athletes. Diagnosis has traditionally been through cardiac catheterization, but more recently has included evaluation with echocardiography, multislice CT, and MRI. Athletes with this condition should be restricted from participation in competitive sports, but can be cleared for participation 6 months after surgical repair. Bicuspid aortic valve is another form of aortic root disease with significance in athletes. Although echocardiography has traditionally been used for diagnosis, CT and MRI have proven more sensitive and specific. Management of bicuspid aortic valve consists of surveillance through echocardiography, medical therapy with beta-blockers and ARBs, and surgery. Guidelines for sports participation are based on the presence of aortic stenosis, aortic regurgitation, and aortic root dilation. Marfan’s syndrome is a genetic disorder with a number of cardiac manifestations including aortic root dilation, aneurysm, and dissection. Medical management involves beta-blockers and ARBs. Thresholds for surgical management differ from the general population. With regard to sports participation, the most important consideration is early detection. Athletes with the stigmata of Marfan’s syndrome or with family history should be tested. Further research should determine whether more aggressive screening is warranted in sports with taller athletes. Athletes with Marfan’s syndrome should be restricted from activities involving collision and heavy contact, avoid isometric exercise, and only participate in activities with low intensity, low dynamic, and low static components. In summary, many forms of aortic root disease afflict athletes and need to be appreciated by sports medicine practitioners because of their potential to lead to tragic but preventable deaths in an otherwise healthy population.

This is a preview of subscription content, access via your institution.

References

  1. Pugh A, Bourke JP, Kunadian V. Sudden cardiac death among competitive adult athletes: a review. Postgrad Med J. 2012;88:382–90.

    PubMed  CAS  Article  Google Scholar 

  2. Ho SY. Structure and anatomy of the aortic root. Eur J Echocardiogr. 2009;10:i3–10.

    PubMed  Article  Google Scholar 

  3. Guiney TE, Davies MJ, Parker DJ, et al. The aetiology and course of isolated severe aortic regurgitation: a clinical, pathological, and echocardiographic study. Br Heart J. 1987;58:358–68.

    PubMed  CAS  Article  Google Scholar 

  4. Seder JD, Burke JF, Pauletto FJ. Prevalence of aortic regurgitation by color flow Doppler in relation to aortic root size. J Am Soc Echocardiogr. 1990;3:316–9.

    PubMed  CAS  Google Scholar 

  5. Roman MJ, Rosen SE, Kramer-Fox R, et al. Prognostic significance of the pattern of aortic root dilation in the Marfan syndrome. J Am Coll Cardiol. 1993;22(5):1470–6.

    PubMed  CAS  Article  Google Scholar 

  6. Maron BJ, Shirani J, Poliac LC, et al. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA. 1996;276(3):199–204.

    PubMed  CAS  Article  Google Scholar 

  7. Basso C, Maron BJ, Corrado D, et al. Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol. 2000;35:1493–501.

    PubMed  CAS  Article  Google Scholar 

  8. Roberts WC. The congenitally bicuspid aortic valve: a study of 85 autopsy studies. Am J Cardiol. 1970;26:72–83.

    PubMed  CAS  Article  Google Scholar 

  9. Hahn RT, Roman MJ, Mogtader AH, et al. Association of aortic dilatation with regurgitant stenotic and functionally normal bicuspid aortic valves. J Am Coll Cardiol. 1992;19:283–8.

    PubMed  CAS  Article  Google Scholar 

  10. Nistri S, Sorbo MD, Marin M, et al. Aortic root dilatation in young men with normally functioning bicuspid aortic valves. Heart. 1999;82:19–22.

    PubMed  CAS  Google Scholar 

  11. Ward C. Clinical significance of the bicuspid aortic valve. Heart. 2000;83:81–5.

    PubMed  CAS  Article  Google Scholar 

  12. Bonow OR, Cheitlin MD, Crawford MH, et al. Task Force 3: valvular heart disease. J Am Coll Cardiol. 2005;45:1334–40.

    PubMed  Article  Google Scholar 

  13. Dietz HC, Pyeritz RE. Mutations in the human gene for Fibrillin-1 in the Marfan syndrome and related disorders. Hum Mol Genet. 1995;4:1799–809.

    PubMed  CAS  Google Scholar 

  14. Robinson PN, Godfrey M. The molecular genetics of Marfan syndrome and related microfibrillopathies. J Med Genet. 2000;37:9–25.

    PubMed  CAS  Article  Google Scholar 

  15. Gibbons GH. The Marfan syndrome: implications for athletes. In: Williams RA, editor. The athlete and heart disease. Riverwoods (IL): Lippincott Williams and Wilkins; 1999. p. 69–78.

    Google Scholar 

  16. De Paepe A, Devereux RB, Dietz HC, et al. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet. 1996;62:417–26.

    PubMed  Article  Google Scholar 

  17. Alizad A, Seward JB. Echocardiographic features of genetic diseases. Part 4. Connective tissue. J Am Soc Echocardiogr. 2000;13:325–30.

    PubMed  CAS  Article  Google Scholar 

  18. Silverman DI, Burton BS, Gray J, et al. Life expectancy in the Marfan syndrome. Am J Cardiol. 1995;75:157–60.

    PubMed  CAS  Article  Google Scholar 

  19. Januzzi JL, Isselbacher EM, Fattori R, et al. Characterizing the young patient with aortic dissection: results from the International Registry of Aortic Dissection (IRAD). J Am Coll Cardiol. 2004;43:665–9.

    PubMed  Article  Google Scholar 

  20. Marsalese DL, Moodie DS, Vacante M, et al. Marfan’s syndrome: natural history and long-term follow-up of cardiovascular involvement. J Am Coll Cardiol. 1989;14:422–8.

    PubMed  CAS  Article  Google Scholar 

  21. Pelliccia A, Di Paolo FM, De Blasiis E, et al. Prevalence and clinical significance of aortic root dilation in highly trained competitive athletes. Circulation. 2010;122:698–706.

    PubMed  Article  Google Scholar 

  22. Kinoshita N, Mimura J, Obayashi C, et al. Aortic root dilatation among young competitive athletes: echocardiographic screening of 1929 athletes between 15 and 34 years of age. Am Heart J. 2000;139:723–8.

    PubMed  CAS  Article  Google Scholar 

  23. Hiratzka LF, Bakris GL, Beckman JA, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: executive summary. J Am Coll Cardiol. 2010;55:e27–129.

    PubMed  Article  Google Scholar 

  24. Pelliccia A, Di Paolo FM, Quattrini FM. Aortic root dilatation in athletic population. Prog Cardiovasc Dis. 2012;54:432–7.

    PubMed  Article  Google Scholar 

  25. Roman MJ, Devereux RB, Kramer-Fox R, et al. Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol. 1989;64:507–12.

    PubMed  CAS  Article  Google Scholar 

  26. Nidorf SM, Picard MH, Triulzi MO, et al. New perspectives in the assessment of cardiac chamber dimensions during development and adulthood. J Am Coll Cardiol. 1992;19:983–8.

    PubMed  CAS  Article  Google Scholar 

  27. Vasan RS, Larson MG, Levy D. Determinants of echocardiographic aortic root size: the Framingham Heart Study. Circulation. 1995;91:734–40.

    PubMed  CAS  Article  Google Scholar 

  28. Reed CM, Richey PA, Pulliam DA, et al. Aortic dimensions in tall men and women. Am J Cardiol. 1993;71:608–10.

    PubMed  CAS  Article  Google Scholar 

  29. Ocak I, Lacomis JM, Deible CR, et al. The aortic root: comparison of measurements from ECG-gated CT angiography with transthoracic echocardiography. J Thorac Imaging. 2009;24:223–6.

    PubMed  Article  Google Scholar 

  30. Tsai SF, Trivedi M, Daniels CJ. Comparing imaging modalities for screening aortic complications in patients with bicuspid aortic valve. Congenit Heart Dis. 2012;7(4):372–7.

    PubMed  Article  Google Scholar 

  31. Nataf P, Lansac E. Dilation of the thoracic aorta: medical and surgical management. Heart. 2006;92:1345–52.

    PubMed  CAS  Article  Google Scholar 

  32. Gao L, Mao Q, Wen D, et al. The effect of beta-blocker therapy on progressive aortic dilatation in children and adolescents with Marfan’s syndrome: a meta-analysis. Acta Paediatr. 2011;100:e101–5.

    PubMed  Article  Google Scholar 

  33. Yetman AT, Bornemeier RA, McCrindle BW. Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome. Am J Cardiol. 2005;95:1125–7.

    PubMed  CAS  Article  Google Scholar 

  34. Brooke BS, Habashi JP, Judge DP, et al. Angiotensin II blockade and aortic-root dilation in Marfan’s syndrome. N Engl J Med. 2008;358:2787–95.

    PubMed  CAS  Article  Google Scholar 

  35. McLoughlin D, McGuinness J, Byrne J, et al. Pravastatin reduces Marfan aortic dilation. Circulation. 2011;124:S168–73.

    PubMed  CAS  Article  Google Scholar 

  36. Mitchell JH, Haskell W, Snell P, et al. Task Force 8: classification of sports. J Am Coll Cardiol. 2005;45:1364–7.

    PubMed  Article  Google Scholar 

  37. Bonow RO, Carabello B, De Leon AC Jr, et al. Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation. 1998;98:1949–84.

    PubMed  CAS  Article  Google Scholar 

  38. Ergin MA, Spielvogel D, Apaydin A, et al. Surgical treatment of the dilated ascending aorta: when and how? Ann Thorac Surg. 1999;67:1834–9.

    PubMed  CAS  Article  Google Scholar 

  39. Ergin MA, McCullough J, Galla JD, et al. Radical replacement of the aortic root in acute type A dissection: indications and outcome. Eur J Cardiothorac Surg. 1996;10:840–5.

    PubMed  CAS  Article  Google Scholar 

  40. Vilacosta I, San Roman JA, Ferreiros J, et al. Natural history and serial morphology of aortic intramural hematoma: a novel variant of aortic dissection. Am Heart J. 1997;134:495–507.

    PubMed  CAS  Article  Google Scholar 

  41. Ergin MA, Raissi S, Follis F, et al. Annular destruction in acute bacterial endocarditis. Surgical techniques to meet the challenge. J Thorac Cardiovasc Surg. 1989;97:755–63.

    PubMed  CAS  Google Scholar 

  42. Lung B, Gohlke-Bärwolf C, Tornos P, et al. Working Group on Valvular Heart Disease. Recommendations on the management of the asymptomatic patient with valvular heart disease. Eur Heart J. 2002;23:1253–66.

    Article  Google Scholar 

  43. Bentall H, De Bono A. A technique for complete replacement of the ascending aorta. Thorax. 1968;23:338–9.

    PubMed  CAS  Article  Google Scholar 

  44. Ross D. Replacement of the aortic valve with a pulmonary autograft: the “switch” operation. Ann Thorac Surg. 1991;52:1346–50.

    PubMed  CAS  Article  Google Scholar 

  45. Sarsam MA, Yacoub M. Remodeling of the aortic valve annulus. J Thorac Cardiovasc Surg. 1993;105:435–8.

    PubMed  CAS  Google Scholar 

  46. Yacoub M, Fagan A, Stassano P, et al. Results of valve conserving operations for aortic regurgitation. Circulation. 1983;68:III321.

    Google Scholar 

  47. Svensson LG. Sizing for modified David’s reimplantation procedure. Ann Thorac Surg. 2003;76:1751–3.

    PubMed  Article  Google Scholar 

  48. Camarda J, Berger S. Coronary artery abnormalities and sudden cardiac death. Pediatr Cardiol. 2012;33(3):434–8.

    PubMed  Article  Google Scholar 

  49. Becker AE, Anderson RH. Coronary artery anomalies. In: Becker AE, Anderson RH, editors. Pathology of congenital heart disease. London: Butterworths; 1981. p. 369–78.

    Google Scholar 

  50. Angelini P. Coronary artery anomalies: an entity in search of an identity. Circulation. 2007;115(10):1296–305.

    PubMed  Google Scholar 

  51. Baltaxe HA, Wixson D. The incidence of congenital anomalies of the coronary arteries in the adult population. Radiology. 1977;122:47–52.

    PubMed  CAS  Google Scholar 

  52. Bunce NH, Lorenz CH, Keegan J, et al. Coronary artery anomalies: assessment with free-breathing three- dimensional coronary MR angiography. Radiology. 2003;227:201–8.

    PubMed  Article  Google Scholar 

  53. Serota H, Barth CW, Seuc CA, et al. Rapid identification of the course of anomalous coronary arteries in adults: the “dot and eye” method. Am J Cardiol. 1990;65:891–8.

    PubMed  CAS  Article  Google Scholar 

  54. Türkvatan A, Güray Y, Altınsoy D. Multidetector computed tomography imaging of coronary artery anomalies. Cardiol Young. 2012;19:1–14.

    Article  Google Scholar 

  55. Shi H, Aschoff AJ, Brambs HJ, et al. Multislice CT imaging of anomalous coronary arteries. Eur Radiol. 2004;14(12):2172–81.

    PubMed  Article  Google Scholar 

  56. Cheitlin MD, MacGregor J. Congenital anomalies of coronary arteries: role in the pathogenesis of sudden cardiac death. Herz. 2009;34(4):268–79.

    PubMed  Article  Google Scholar 

  57. Mofrad PS, Weigold G, Clavijo LC. Sudden cardiac death in athlete with anomalous single coronary artery. Cardiovasc Revasc Med. 2005;6:89–90.

    PubMed  Article  Google Scholar 

  58. Basso C, Frescura C, Corrado D, et al. Congenital heart disease and sudden death in the young. Hum Pathol. 1995;26:1065–72.

    PubMed  CAS  Article  Google Scholar 

  59. Frescura C, Basso C, Thiene G, et al. Anomalous origin of coronary arteries and risk of sudden death: a study based on an autopsy population of congenital heart disease. Hum Pathol. 1998;29:689–95.

    PubMed  CAS  Article  Google Scholar 

  60. Frommelt PC. Congenital coronary artery abnormalities predisposing to sudden cardiac death. Pacing Clin Electrophysiol. 2009;32(Suppl 2):S63–6.

    PubMed  Article  Google Scholar 

  61. Lee AC, Foster E, Yeghiazarians Y. Anomalous origin of the left coronary artery from the pulmonary artery: a case series and brief review. Congenit Heart Dis. 2006;1:111–5.

    PubMed  Article  Google Scholar 

  62. Post JC, van Rossum AC, Bronzwaer JG, et al. Magnetic resonance angiography of anomalous coronary arteries. A new gold standard for delineating the proximal course? Circulation. 1995;92:3163–71.

    PubMed  CAS  Article  Google Scholar 

  63. Taylor AJ, Rogan KM, Virmani R. Sudden cardiac death associated with isolated congenital coronary artery anomalies. J Am Coll Cardiol. 1992;20:640–7.

    PubMed  CAS  Article  Google Scholar 

  64. Garg N, Tewari S, Kapoor A, et al. Primary congenital anomalies of the coronary arteries: a coronary arteriographic study. Int J Cardiol. 2000;74:39–46.

    PubMed  CAS  Article  Google Scholar 

  65. Angelini P. Coronary artery anomalies—current clinical issues, definitions, classification, incidence, clinical relevance, and treatment guidelines. Tex Heart Inst J. 2002;29:271–8.

    PubMed  Google Scholar 

  66. Graham TP Jr, Bricker JT, James FW, et al. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 1: congenital heart disease. J Am Coll Cardiol. 1994;24(4):867–73.

    PubMed  Article  Google Scholar 

  67. Maron BJ, Zipes DP. Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities—general considerations. J Am Coll Cardiol. 2005;45:1318.

    PubMed  Article  Google Scholar 

  68. Jaggers J, Lodge AJ. Surgical therapy for anomalous aortic origin of the coronary arteries. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2005;8:122–7.

    Google Scholar 

  69. Doorey AJ, Pasquale MJ, Lally JF, et al. Six month success of intracoronary stenting for anomalous coronary arteries associated with myocardial ischemia. Am J Cardiol. 2000;86:580–2.

    PubMed  CAS  Article  Google Scholar 

  70. Romp RL, Herlong RL, Landolfo CK, et al. Outcome of unroofing procedure for repair of anomalous aortic origin of left or right coronary artery. Ann Thorac Surg. 2003;76:589–96.

    PubMed  Article  Google Scholar 

  71. Frommelt PC, Frommelt MA, Tweddell JS, et al. Prospective echocardiographic diagnosis and surgical repair of anomalous origin of a coronary artery from the opposite sinus with an interarterial course. J Am Coll Cardiol. 2003;42:148–54.

    PubMed  Article  Google Scholar 

  72. Sievers HH, Schmidtke C. A classification system for the bicuspid aortic valve from 304 surgical specimens. J Thorac Cardiovasc Surg. 2007;133:1226–33.

    PubMed  Article  Google Scholar 

  73. Osler W. The bicuspid condition of the aortic valve. Trans Assoc Am Phys. 1886;2:185–92.

    Google Scholar 

  74. Basso C, Boschello M, Perrone C, et al. An echocardiographic survey of primary school children for bicuspid aortic valve. Am J Cardiol. 2004;93:661–3.

    PubMed  Article  Google Scholar 

  75. Clementi M, Notari L, Borghi A, et al. Familial congenital bicuspid aortic valve: a disorder of uncertain inheritance. Am J Med Genet. 1996;62:336–8.

    PubMed  CAS  Article  Google Scholar 

  76. Glick BN, Roberts WC. Congenitally bicuspid aortic valve in multiple family members. Am J Cardiol. 1994;73:400–4.

    PubMed  CAS  Article  Google Scholar 

  77. Brandenburg RO Jr, Tajik AJ, Edwards WD, et al. Accuracy of 2-dimensional echocardiographic diagnosis of congenitally bicuspid aortic valve: echocardiographic-anatomic correlation in 115 patients. Am J Cardiol. 1983;51(9):1469–73.

    PubMed  Article  Google Scholar 

  78. Espinal M, Fuisz AR, Nanda NC, et al. Sensitivity and specificity of transesophageal echocardiography for determination of aortic valve morphology. Am Heart J. 2000;139(6):1071–6.

    PubMed  CAS  Article  Google Scholar 

  79. Gleeson TG, Mwangi I, Horgan SJ, et al. Steady-state free-precession (SSFP) cine MRI in distinguishing normal and bicuspid aortic valves. J Magn Reson Imaging. 2008;28(4):873–8.

    PubMed  Article  Google Scholar 

  80. Manghat NE, Rachapalli V, Van Lingen R, et al. Imaging the heart valves using ECG-gated 64-detector row cardiac CT. Br J Radiol. 2008;81(964):275–90.

    PubMed  CAS  Article  Google Scholar 

  81. Bennett CJ, Maleszewski JJ, Araoz PA. CT and MR imaging of the aortic valve: radiologic–pathologic correlation. Radiographics. 2012;32(5):1399–420.

    PubMed  Article  Google Scholar 

  82. Fernandes S, Khairy P, Graham DA, et al. Bicuspid aortic valve and associated aortic dilation in the young. Heart. 2012;98(13):1014–9.

    PubMed  Article  Google Scholar 

  83. Yuan SM, Jing H, Lavee J. The bicuspid aortic valve and its relation to aortic dilation. Clinics (Sao Paulo). 2010;65(5):497–505.

    Article  Google Scholar 

  84. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). J Am Coll Cardiol. 2008;52:e1–121.

    Article  Google Scholar 

  85. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease). J Am Coll Cardiol. 2006;48:e1–148.

    PubMed  Article  Google Scholar 

  86. Rao V, Van Arsdell GS, David TE, et al. Aortic valve repair for adult congenital heart disease: a 22-year experience. Circulation. 2000;102:III40–3.

    PubMed  CAS  Google Scholar 

  87. Hiratzka LF, Bakris GL, Beckman JA, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation. 2010;121(13):e266–369.

    PubMed  Article  Google Scholar 

  88. Tzemos N, Therrien J, Yip J, et al. Outcomes in adults with bicuspid aortic valves. JAMA. 2008;300:1317–25.

    PubMed  CAS  Article  Google Scholar 

  89. Bonow RO, Cheitlin MD, Crawford MH, Douglas PS. Task Force 3: valvular heart disease. J Am Coll Cardiol. 2005;45(8):1334–40.

    PubMed  Article  Google Scholar 

  90. Yuan SM, Jing H. Marfan’s syndrome: an overview. Sao Paulo Med J. 2010;128(6):360–6.

    PubMed  Google Scholar 

  91. Brown OR, DeMots H, Kloster FE, et al. Aortic root dilatation and mitral valve prolapse in Marfan’s syndrome: an echocardiographic study. Circulation. 1975;52(4):651–7.

    PubMed  CAS  Article  Google Scholar 

  92. Iserin L, Jondeau G, Sidi D, et al. Marfan’s syndrome. Cardiovascular manifestations and therapeutic indications. Arch Mal Coeur Vaiss. 1997;90(12 Suppl):1701–5.

    PubMed  CAS  Google Scholar 

  93. Hartog AW, Franken R, Zwinderman AH, et al. Current and future pharmacological treatment strategies with regard to aortic disease in Marfan syndrome. Expert Opin Pharmacother. 2012;13(5):647–62.

    PubMed  CAS  Article  Google Scholar 

  94. Shores J, Berger KR, Murphy EA, et al. Progression of aortic dilatation and the benefit of long-term [beta]-adrenergic blockade in Marfan’s syndrome. N Engl J Med. 1994;330:1335–41.

    PubMed  CAS  Article  Google Scholar 

  95. Tahernia AC. Cardiovascular anomalies in Marfan’s syndrome: the role of echocardiography and beta-blockers. South Med J. 1993;86(3):305–10.

    PubMed  CAS  Article  Google Scholar 

  96. Akhurst RJA. Sweet link between TGF β and vascular disease. Nat Genet. 2006;38(4):400–1.

    PubMed  CAS  Article  Google Scholar 

  97. Brooke BS, Habashi JP, Judge DP, et al. Angiotensin II blockade and aortic-root dilation in Marfan’s syndrome. N Engl J Med. 2008;358(26):2787–95.

    PubMed  CAS  Article  Google Scholar 

  98. Kallenbach K, Schwill S, Karck M. Modern aortic surgery in Marfan syndrome–2011. Herz. 2011;36(6):505–12.

    PubMed  CAS  Article  Google Scholar 

  99. Gott VL, Laschinger JC, Cameron DE, et al. The Marfan syndrome and the cardiovascular surgeon. Eur J Cardiothorac Surg. 1996;10:149–58.

    PubMed  CAS  Article  Google Scholar 

  100. Braverman AC. Exercise and the Marfan syndrome. Med Sci Sports Exerc. 1998;30(10 Suppl):S387–95.

    PubMed  CAS  Google Scholar 

  101. Mitchell JH, Haskell WL, Raven PB. Revised eligibility: recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol. 1994;24:864–6.

    PubMed  CAS  Article  Google Scholar 

  102. Rost R, Schneider KW, Stegmann N. Comparative echocardiographic studies on the hearts of competitive athletes and of untrained persons. Med Welt. 1972;23(33):1088–93.

    PubMed  CAS  Google Scholar 

  103. Morganroth J, Maron BJ, Henry WL, et al. Comparative left ventricular dimensions in trained athletes. Ann Intern Med. 1975;82(4):521–4.

    PubMed  CAS  Article  Google Scholar 

  104. Yim ES, Corrado G. Ultrasound in sports medicine: relevance of emerging techniques to clinical care of athletes. Sports Med. 2012;42(8):665–80.

    PubMed  Article  Google Scholar 

  105. Yim ES, Gillis EF, Ojala K, et al. Focused transthoracic echocardiography by sports medicine physicians: measurements relevant to hypertrophic cardiomyopathy. J Ultrasound Med. 2013;32(2):333–8.

    Google Scholar 

Download references

Acknowledgements

No funding was used in the preparation of this manuscript. There were no conflicts of interest to disclose. There were no other parties involved in the preparation of this manuscript.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Eugene Sun Yim.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Yim, E.S. Aortic Root Disease in Athletes: Aortic Root Dilation, Anomalous Coronary Artery, Bicuspid Aortic Valve, and Marfan’s Syndrome. Sports Med 43, 721–732 (2013). https://doi.org/10.1007/s40279-013-0057-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40279-013-0057-6

Keywords

  • Aortic Valve
  • Left Anterior Descend
  • Sudden Cardiac Death
  • Aortic Stenosis
  • Aortic Root